AI Pathology AI Specialist Interview Questions

A great answer covers gigapixel resolution, formats like SVS, NDPI, TIFF, and the role of OpenSlide as a universal reader.

Answer should cover morphological vs. protein-expression-based stains and the implications for feature learning and normalization.

A strong answer explains gigapixel scale, loss of morphological detail at low resolution, and the need for patch-based or multi-scale approaches.

Covers weak supervision from slide-level labels, bags of patches, and how MIL avoids the need for pixel-level annotations.

Expect references to prostate cancer (Gleason grading), breast cancer (lymph node metastasis), and colorectal cancer (MSI prediction).

Should cover tissue detection, foreground masking, tiling at 20× or 40×, quality filtering, color normalization, and feature extraction.

Answer should contrast max-pooling aggregation with attention-weighted pooling, interpretability via attention heatmaps, and subtyping with clustering.

Covers singular value decomposition in optical density space, limitations with tissue types lacking expected stain vectors, and failure on IHC.

Should discuss scanner variability, staining batch effects, and solutions like stain normalization, domain adaptation, and federated learning.

Expect discussion of pseudo-labeling, self-supervised pre-training (e.g., SimCLR, DINO), weakly supervised MIL, and active learning.

Covers Cohen's kappa for ordinal grading, quadratic weighted kappa, sensitivity/specificity per grade, concordance with pathologist panels.

Should describe patch-level pre-training on unlabeled WSIs, contrastive learning, and downstream fine-tuning with limited labels.

Answer covers DICOM Supplement 145, standardized WSI encoding, interoperability with PACS/VNA, and vendor-neutral clinical integration.

Covers high-throughput biomarker studies, core-level annotation, automated core detection, and population-level statistical analysis.

Expect discussion of focal loss, class-weighted sampling, synthetic augmentation (stain/rotation), and curriculum learning strategies.

Should cover tumor cell segmentation, immune cell detection, TPS/CPS computation, spatial scoring thresholds, and concordance with pathologist scoring.

Covers FedAvg/FedProx, communication-efficient gradient updates, non-IID data challenges, and differential privacy for patient protection.

Answer should cover large-scale pre-training on millions of patches, zero/few-shot transfer, multi-modal pathology-language alignment, and reduced annotation burden.

Expect analysis of scanner differences, staining protocol variations, patient demographics, label noise, patch-level feature distribution shifts, and targeted remediation.

Covers locked vs. adaptive algorithms, SaMD framework, modification protocols, performance monitoring triggers, and re-validation procedures.

Should discuss shared encoder with task-specific heads, loss weighting, auxiliary task regularization, and clinical utility of 'stain-free' molecular inference.

Covers Monte Carlo dropout, deep ensembles, conformal prediction, temperature scaling, and presenting uncertainty in clinician-friendly visualizations.

Expect discussion of tile-level batching, GPU memory management, spatial indexing, streaming inference, and cost-optimized cloud GPU strategies.

Covers cell graph construction, spatial relationship encoding, message passing for immune cell-tumor interaction modeling, and applications in immunotherapy response prediction.

Should cover blur detection, tissue folding detection, air bubble identification, pen marking removal, and integration with scanner QC workflows.

Answer covers reviewing concordance metrics per grade, checking scanner/staining differences, examining edge-case slides with the clinical team, and calibrating decision thresholds.

Expect self-supervised pre-training on all 5,000 slides, MIL-based weakly supervised training, cross-validation, and validation against an external MSI-confirmed cohort.

Covers FDA/EMA companion diagnostic requirements, lock-down of algorithm version, clinical trial integration, CAP/CLIA laboratory compliance, and prospective validation design.

Should address on-premise edge deployment, model compression/quantization, offline inference capability, scanner compatibility testing, and local pathology expert collaboration.

Covers distribution bias, suboptimal performance on rare pediatric subtypes, strategies for rare disease augmentation, and ethical implications of deploying biased models.

Expect respectful clinical collaboration, review of attention maps vs. the missed region, annotation of the missed focus for retraining, and communication about model limitations.

Should discuss cancer-type-aware conditioning, shared feature extraction with cancer-specific heads, large-scale pre-training, and benchmarking per-cancer performance.

Covers data migration (WSIs are TB-scale), DICOM service reconfiguration, containerized model portability, cost model re-evaluation, and re-validation on new infrastructure.

Covers the impact on model ceiling performance, the need for refined annotation guidelines, adjudication panels, consensus labeling protocols, and honest reporting of reference standard limitations.

Answer should cover scanner-specific QC testing, color calibration pipelines, domain adaptation if needed, and inclusion in a continuous validation framework.

Covers GDC data portal download, OpenSlide preprocessing, tissue detection and tiling, feature extraction with a pretrained ResNet, CLAM training with k-fold cross-validation, and attention heatmap visualization.

Should cover MONAI transforms (RandFlip, RandRotate, NormalizeIntensity), UNet architecture configuration, DiceLoss, and sliding window inference for large images.

Covers project organization, run grouping, hyperparameter sweeps, artifact versioning for datasets/models, and dashboard creation for cross-team comparison.

Covers QuPath project setup, annotation tools (polygon, brush), scripting for batch processing, export to GeoJSON, and conversion to training-compatible formats.

Should discuss model containerization with Docker, DICOMweb endpoint setup, slide ingestion via STOW-RS, inference orchestration, and result retrieval via WADO-RS.

Covers Clara's pre-built pathology models, federated learning support, MONAI integration, optimized data loaders for WSIs, and enterprise-grade deployment features.

Covers choosing a reference image, Macenko/Vahadane method selection, batch normalization across a cohort, visual quality assessment, and integration into a preprocessing pipeline.

Covers model card creation with clinical metadata, ONNX export for portability, Inference API setup, and community engagement via discussions and citations.

Should cover workflow definition with processes for tiling, feature extraction, model inference, and result aggregation, with SLURM/Cloud integration for parallel execution.

Covers memory-mapped tile databases (e.g., HDF5), on-the-fly augmentation, balanced sampling across slides, multi-resolution loading, and avoiding OOM errors.

Look for clear communication strategy, use of visualizations, patience, and ability to translate ML metrics into clinical impact language.

Expect structured problem-solving, root cause analysis (data drift, pipeline bug, etc.), stakeholder communication, and implementation of monitoring safeguards.

Should demonstrate respect for clinical expertise, evidence-based dialogue using attention maps and case reviews, and willingness to update models based on clinical feedback.

Look for practical data cleaning strategies, documentation of data quality issues, transparent reporting, and pragmatic decision-making about acceptable noise levels.

Expect mention of specific journals, conferences (MICCAI, USCAP), preprint servers, Slack/Discord communities, and a systematic approach to literature review.